Clinical Trial Update: Use Of Oral Fidaxomicin Vs. Oral Vancomycin For Clostridium Difficile Infection In Patients With Spinal Cord Injury [Phase 4]

View source ↗

Summary

Phase 4 trial comparing oral fidaxomicin to oral vancomycin for Clostridioides difficile infection in patients with spinal cord injury was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection
• Spinal Cord Injury

Drugs mentioned

• Dificid (fidaxomicin)
• Vancocin (vancomycin)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Clostridium Difficile, Spinal Cord Injury | Phase 4 | Status: TERMINATED